Treovir has launched a Phase 2 clinical trial to assess the safety and efficacy of G207, an experimental virus-based therapy, for pediatric recurrent high-grade…
Glioma
Researchers have uncovered genetic changes that may explain why certain brain tumors, known as gliomas, that are associated with IDHÂ gene mutations start off as…
U.S. scientists have discovered that pediatric low-grade gliomas — a type of brain cancer that can occur in children — are generally softer than normal…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to MB-108, an experimental virus-based therapy that Mustang Bio is developing for…
Recent Posts
- Researchers say multiple myeloma patients are living longer
- Daily pill to stop pancreatic cancer spread granted FDA orphan drug status
- How to practice being an imperfect (but compassionate) caregiver
- New cell therapy for glioblastoma doubles progression-free survival
- Oral treatment for ovarian cancer put on FDA fast track
